Atlas Trials

UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer

Clinical trial NCT00570232 · COMPLETED

Trial details

NCT number
NCT00570232
Sponsor
University of Alabama at Birmingham
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2007-12-01
Primary completion
2014-12-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.